Press Releases Press Releases Year None202420232022202120202019201820172016201520142013201120102009200820072005 June 18, 2024 Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder PDF Version June 10, 2024 Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference PDF Version May 29, 2024 Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference PDF Version May 23, 2024 Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting PDF Version May 8, 2024 Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences PDF Version May 7, 2024 Intra-Cellular Therapies Reports First Quarter 2024 Financial Results PDF Version April 30, 2024 Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast PDF Version April 24, 2024 Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares PDF Version April 17, 2024 Intra-Cellular Therapies Prices Public Offering of Common Stock PDF Version April 16, 2024 Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock PDF Version Pagination Current page 1 Page 2 Next page next › Last page last »
June 18, 2024 Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder PDF Version
June 10, 2024 Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference PDF Version
May 29, 2024 Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference PDF Version
May 23, 2024 Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting PDF Version
April 30, 2024 Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast PDF Version
April 24, 2024 Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares PDF Version
April 16, 2024 Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock PDF Version